Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Epistaxis01:30

Epistaxis

845
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
845
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-drug conjugate sequencing in HER2-positive metastatic breast cancer: Real-world outcomes of trastuzumab deruxtecan with and without prior T-DM1 exposure.

Breast (Edinburgh, Scotland)·2026
Same author

Alterations in vaginal microbiome in women with short cervix: longitudinal study of microbial diversity and impact of vaginal progesterone treatment.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same author

Integrating infection prevention into antimicrobial stewardship: a dual strategy for neonatal intensive care unit stewardship.

The Journal of hospital infection·2025
Same author

Novel heterogeneity method for predicting survival in non-metastatic triple-negative breast cancer.

Revista espanola de medicina nuclear e imagen molecular·2025
Same author

Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function.

Actas urologicas espanolas·2024
Same author

Neutralizing antibody levels and cellular immune response against Omicron variant in pregnant women vaccinated with mRNA and inactivated SARS-CoV-2 vaccines.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2023

Related Experiment Video

Updated: Apr 24, 2026

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

Published on: April 25, 2025

1.4K

Is topical corticosteroid necessary in traumatic hyphema?

E B Türkoğlu1, T Celik2, E Celik3

  • 1Akdeniz University, Department of Ophthalmology, 07100 Antalya, Turkey.

Journal Francais D'Ophtalmologie
|September 10, 2014
PubMed
Summary

Topical corticosteroids did not improve outcomes for traumatic hyphema compared to supportive therapy alone. Supportive care alone is a convenient and cost-effective strategy for uncomplicated traumatic hyphema management.

Keywords:
Corticostéroïdes topiquesHyphemaHyphémaInjury traumaticLésion traumatiqueSteroidStéroïdesTopical corticosteroidTrauma bluntTrauma eyeTrauma ocularTraumatisme contondantTraumatisme oculaire

More Related Videos

Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration
07:39

Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration

Published on: August 4, 2023

3.5K
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

1.4K

Related Experiment Videos

Last Updated: Apr 24, 2026

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

Published on: April 25, 2025

1.4K
Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration
07:39

Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration

Published on: August 4, 2023

3.5K
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

1.4K

Area of Science:

  • Ophthalmology
  • Trauma Care

Background:

  • Traumatic hyphema management often involves supportive care.
  • The role of adjunctive topical corticosteroids is debated.

Purpose of the Study:

  • To compare outcomes of traumatic hyphema treated with topical corticosteroids plus supportive therapy versus supportive therapy alone.

Main Methods:

  • Retrospective study of 206 patients with traumatic hyphema.
  • Group I (98 eyes): topical corticosteroids + supportive therapy.
  • Group II (108 eyes): supportive therapy alone. Evaluated hyphema size, visual acuity, intraocular pressure, clearance time, and rebleeding.

Main Results:

  • No significant difference in hyphema resorption time (P=0.62) or rebleeding rates (P=0.67) between groups.
  • Initial and final visual acuities were similar (P=0.86).
  • Intraocular pressure was significantly higher in the corticosteroid group (19.7 mmHg) vs. supportive care alone (14.2 mmHg) (P=0.04).

Conclusions:

  • Topical corticosteroids did not reduce rebleeding or improve visual outcomes in traumatic hyphema.
  • Supportive therapy alone is a viable, cost-effective strategy for uncomplicated cases.
  • Higher intraocular pressure observed with corticosteroid use warrants consideration.